Advertisements


Innate Pharma reports first half 2019 financial results and business update

INNATE PHARMA REPORTS FI.....»»

Category: earningsSource: benzingaSep 13th, 2019

Innate Pharma Reports Full Year 2019 Financial Results and Business Update

Innate globally expands its capital markets presence with a successful NASDAQ IPO and Global Offering that provided gross proceeds of $79.1 million (€71.5 million1) Monalizumab to advance t.....»»

Category: earningsSource: benzingaMar 10th, 2020

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019

Conference call and webcast on Wednesday, September 18at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancr.....»»

Category: earningsSource: benzingaSep 17th, 2019

Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update

TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma (NASDAQ/TASE: KTOV), an innovative pharmaceutical company, today reported its unaudited financial results for the year ended December 31, 2018 and provided a business update. Highligh.....»»

Category: earningsSource: benzingaFeb 7th, 2019

Onxeo Reports Full-Year 2019 Financial Results and Provides Business Update

Cash position of €5.7 million at December 31, 2019, combined with $6.6 million from new agreement with Acrotech, provide extended financial visibility into Q2 202.....»»

Category: earningsSource: benzingaApr 17th, 2020

GenScript Biotech Reports 2019 Financial Results and Provides Business Update

NANJING, China, March 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, yesterday reported full year 2019 financ.....»»

Category: earningsSource: benzingaMar 31st, 2020

RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused o.....»»

Category: earningsSource: benzingaMar 30th, 2020

PDS Biotechnology Reports Full Year 2019 Financial Results and Provides Business Update

PRINCETON, N.J., March 27, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation ("PDS Biotechnology") (NASDAQ:PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on T-cell.....»»

Category: earningsSource: benzingaMar 27th, 2020

Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update

Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaMar 26th, 2020

OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for Potential Impact of COVID-19 on the Company"s Clinical Development Activities

OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for Potential Impact of COVID-19 on the Company"s Clinical Development Activities.....»»

Category: earningsSource: benzingaMar 26th, 2020

Pulmatrix Reports 2019 Financial Results and Provides Business Update

LEXINGTON, Mass., March 26, 2020 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ:PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to addres.....»»

Category: earningsSource: benzingaMar 26th, 2020

Sprott Resource Holdings Inc. Business Update and Reports 2019 Annual Results

TORONTO, March 25, 2020 (GLOBE NEWSWIRE) -- (TSX:SRHI) - Sprott Resource Holdings Inc. ("SRHI" or the "Company") today announced its operating and financial results for the year ended December 31, 2019. The Comp.....»»

Category: earningsSource: benzingaMar 25th, 2020

Celyad Reports Full Year 2019 Financial Results and Provides Business Update

First patient successfully dosed in.....»»

Category: earningsSource: benzingaMar 24th, 2020

IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 24, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using .....»»

Category: earningsSource: benzingaMar 24th, 2020

Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update

LEXINGTON, Mass., March 19, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focus.....»»

Category: earningsSource: benzingaMar 19th, 2020

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update.....»»

Category: earningsSource: benzingaMar 19th, 2020

Diffusion Pharmaceuticals Reports 2019 Financial Results and Provides Business Update

$16.2 Million in Gross Proceeds Raised Now Enrolling in Acute Stroke Trial GBM Data Presented New.....»»

Category: earningsSource: benzingaMar 17th, 2020

ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019

More than two-thirds of .....»»

Category: earningsSource: benzingaMar 16th, 2020

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.....»»

Category: earningsSource: benzingaMar 16th, 2020

Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results

RADNOR, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a busi.....»»

Category: earningsSource: benzingaMar 16th, 2020

Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business Update

NORCROSS, Ga., March 1.....»»

Category: earningsSource: benzingaMar 16th, 2020